Skip to main content
SpringerLink
Log in

Lipid Lowering Drugs and Coronary Heart Disease

  • Special Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Keys, A.; Aravanis, C.; Blackburn, H.; van Buchem, F.S.P.; Buzina, R.; Djordjevic, B.S.; Fidanza, F.; Karvonen, M.J.; Menotti, A.; Puddu, V. and Taylor, H.L.: Probability of middle-aged men developing coronary heart disease in five years. Circulation 45: 815–828 (1972).

    Article  PubMed  CAS  Google Scholar 

  2. Christie, D.: Mortality from cardiovascular disease. Medical Journal of Australia 1: 390–393 (1974).

    PubMed  CAS  Google Scholar 

  3. Corday, E. and Corday, S.R.: Prevention of heart disease by control of risk factors: The time has come to face facts. American Journal of Cardiology 35: 330–333 (1975).

    Article  PubMed  CAS  Google Scholar 

  4. Armstrong, M.L.; Warner, E.D. and Connor, W.E.: Regression of coronary atheromatosis in rhesus monkeys. Circulation Research 27: 59–67 (1970).

    Article  PubMed  CAS  Google Scholar 

  5. Gillam, P.M.S.: The value of clofibrate in coronary heart disease. American Heart Journal 87: 1–4 (1974).

    Article  PubMed  CAS  Google Scholar 

  6. Nye, E.R.: Current status of clofibrate therapy. New Ethicals and Medical Progress 11 (No. 8): 17–18 (Aug. 1974).

    Google Scholar 

  7. Physicians of the Newcastle upon Tyne Region: Trial of clofibrate in the treatment of ischaemic heart disease. Brit. med. J. 4: 767–775 (1971).

    Article  Google Scholar 

  8. Research Committee of the Scottish Society of Physicians: Ischaemic heart disease: A secondary prevention trial using clofibrate. British Medical Journal 4: 775–784 (1971).

    Article  Google Scholar 

  9. Krasno, L.R. and Kidera, G.J.: Clofibrate in coronary heart disease. Effect on morbidity and mortality. Journal of the American Medical Association 219: 845–851 (1972).

    CAS  Google Scholar 

  10. The Coronary Drug Project Research Group: Clofibrate and niacin in coronary heart disease. Journal of the American Medical Association 231: 360–381 (1975).

    Article  Google Scholar 

  11. Keys, A.; Aravanis, C.; Blackburn, H.W.; van Buchem, F.S.P.; Buzina, R.; Djordjevic, B.S.; Dontas, A.S.; Fidanza, F.; Karvonen, M.J.; Kimura, N.; Lekos, D.; Monti, M.; Puddu, V. and Taylor, H.L.: Epidemiological studies related to coronary heart disease: Characteristics of men aged 40–59 in seven countries. Acta Medica Scandinavica 181 (Suppl.): 1–392 (1967).

    Google Scholar 

  12. Hirsch, S.B.; Wechsler, A.F. and Tourtellotle, W.W.: Clofibrate for the treatment of occlusive cerebrovascular disease. New England Journal of Medicine 287: 671 (1972).

    PubMed  CAS  Google Scholar 

  13. University Group Diabetes Program: A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl. 2): 747–783, 789–830 (1970).

    Google Scholar 

  14. University Group Diabetes Program: Effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenformin results. Journal of the American Medical Association 217: 777–784 (1971).

    Article  Google Scholar 

  15. Heady, J.A.: A co-operative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress. Bulletin of the World Health Organisation.

  16. The Committee on Diet and Heart Disease of the National Heart Foundation of Australia: Dietary fat and coronary heart disease: A review. Medical Journal of Australia 1: 575–579, 616–620, 663–668 (1974).

    Google Scholar 

  17. Dayton, S.; Pearce, M.L.; Hashimoto, S.; Dixon, W.I. and Tomiyasu, U.: A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 40 (Suppl. 2): 1–63 (1969).

    Article  Google Scholar 

  18. Miettinen, M.; Turpeinen, O.; Karvonen, M.J.; Elosuo, R. and Paavalainen, E.: Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Lancet 2: 835–838 (1972).

    Article  PubMed  CAS  Google Scholar 

  19. Grundy, S.M.; Ahrens, E.H.; Salen, G.; Schreibman, P.H. and Nestel, P.J.: Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. Journal of Lipid Research 13: 531–551 (1972).

    PubMed  CAS  Google Scholar 

  20. Scott, P.J. and Hurley, P.J.: Effect of clofibrate on low density lipoprotein turnover in essential hypercholesteralaemia. Journal of Atherosclerosis Research 9: 25–34 (1970).

    Article  Google Scholar 

  21. Schubert, W.K.: Fat nutrition and diet in childhood. American Journal of Cardiology 31: 581–587 (1973).

    Article  PubMed  CAS  Google Scholar 

  22. Kannel, W.B.: Prevention of coronary heart disease by control of risk factors. Journal of the American Medical Association 227: 338 (1974).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, The University of Auckland School of Medicine, Park Road, Auckland, New Zealand

    P. J. Scott

Authors
  1. P. J. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scott, P.J. Lipid Lowering Drugs and Coronary Heart Disease. Drugs 10, 218–225 (1975). https://doi.org/10.2165/00003495-197510030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197510030-00004

Keywords

Search

Navigation